MADELINE MOSKALUK: Open Payments
NPI 1770268526 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$227 in 11 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $227
Food & beverage: $227
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Mallinckrodt Hospital Products Inc. | 1 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $39 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $37 |
| Lundbeck LLC | 2 | $33 |
| CATALYST PHARMACEUTICALS, INC. | 1 | $23 |
| IBSA Pharma Inc. | 1 | $15 |
Products named: HYQVIA, ACTHAR, RELISTOR, JOURNAVX, VYEPTI, FIRDAPSE, Tirosint.
Industry payments across NY — which companies pay providers there.
